Detalhe da pesquisa
1.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
N Engl J Med
; 388(3): 228-239, 2023 01 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36652354
2.
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet
; 401(10372): 195-203, 2023 01 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36681415
3.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10391): 1853-1865, 2023 06 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37075781
4.
Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract Cancer: An Exploratory Analysis of JCOG1113.
Oncologist
; 29(1): e97-e107, 2024 Jan 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37531645
5.
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.
Hepatology
; 78(3): 758-770, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36999533
6.
Multicenter validation study of a treatment selection MAP for pancreatic neuroendocrine tumors.
Jpn J Clin Oncol
; 2024 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38677983
7.
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan.
Int J Clin Oncol
; 29(4): 456-463, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38353906
8.
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study.
Int J Clin Oncol
; 29(2): 188-194, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37991558
9.
A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT).
Ann Surg Oncol
; 30(12): 7331-7337, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37450093
10.
Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
Invest New Drugs
; 41(6): 777-786, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37856005
11.
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
BMC Cancer
; 23(1): 177, 2023 Feb 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36809997
12.
Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pancreas Society (JPS) 2022 in Kyoto.
Pancreatology
; 23(6): 682-688, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37507301
13.
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines).
Hepatol Res
; 53(5): 383-390, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36826411
14.
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).
Future Oncol
; 19(38): 2505-2516, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37671641
15.
Liposomal irinotecan with fluorouracil and leucovorin after gemcitabine-based therapy in Japanese patients with metastatic pancreatic cancer: additional safety analysis of a randomized phase 2 trial.
Jpn J Clin Oncol
; 53(2): 130-137, 2023 Jan 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36412114
16.
Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment.
Jpn J Clin Oncol
; 53(9): 764-773, 2023 Aug 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37325968
17.
Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106.
Jpn J Clin Oncol
; 53(8): 704-713, 2023 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37248668
18.
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 23(1): 77-90, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34914889
19.
A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
Cancer
; 128(10): 2025-2035, 2022 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35195274
20.
Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer.
Ann Surg
; 275(4): e652-e658, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32826389